News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,195 Results
Type
Article (41810)
Company Profile (329)
Press Release (663056)
Section
Business (210187)
Career Advice (2079)
Deals (36575)
Drug Delivery (96)
Drug Development (82795)
Employer Resources (171)
FDA (16476)
Job Trends (15358)
News (355446)
Policy (33818)
Tag
Academia (2576)
Alliances (51089)
Alzheimer's disease (1246)
Approvals (16407)
Artificial intelligence (140)
Bankruptcy (362)
Best Places to Work (11669)
Biotechnology (214)
Breast cancer (122)
Cancer (1104)
Cardiovascular disease (102)
Career advice (1739)
Cell therapy (236)
Clinical research (65774)
Collaboration (394)
Compensation (199)
COVID-19 (2601)
C-suite (96)
Data (1128)
Diabetes (154)
Diagnostics (6224)
Earnings (86502)
Employer resources (149)
Events (112352)
Executive appointments (319)
FDA (17020)
Funding (355)
Gene therapy (187)
GLP-1 (609)
Government (4445)
Healthcare (18852)
Infectious disease (2686)
Inflammatory bowel disease (110)
Interviews (319)
IPO (16574)
Job creations (4051)
Job search strategy (1489)
Layoffs (433)
Legal (8318)
Lung cancer (172)
Manufacturing (185)
Medical device (13263)
Medtech (13268)
Mergers & acquisitions (20068)
Metabolic disorders (419)
Neuroscience (1530)
NextGen Class of 2024 (6629)
Non-profit (4514)
Northern California (1485)
Obesity (241)
Opinion (203)
Patents (105)
People (58279)
Pharmaceutical (92)
Phase I (20342)
Phase II (28948)
Phase III (21711)
Pipeline (457)
Postmarket research (2643)
Preclinical (8677)
Radiopharmaceuticals (241)
Rare diseases (228)
Real estate (6240)
Regulatory (22360)
Research institute (2358)
Resumes & cover letters (360)
Southern California (1305)
Startups (3712)
United States (13620)
Vaccines (567)
Weight loss (182)
Date
Today (132)
Last 7 days (791)
Last 30 days (3832)
Last 365 days (36190)
2024 (33193)
2023 (40632)
2022 (51801)
2021 (56338)
2020 (54803)
2019 (47413)
2018 (35780)
2017 (33140)
2016 (32665)
2015 (38621)
2014 (32518)
2013 (27633)
2012 (29735)
2011 (30487)
2010 (28500)
Location
Africa (776)
Arizona (199)
Asia (39991)
Australia (6393)
California (3344)
Canada (1292)
China (252)
Colorado (147)
Connecticut (155)
Europe (85161)
Florida (459)
Georgia (116)
Illinois (348)
Indiana (204)
Kansas (96)
Maryland (581)
Massachusetts (2647)
Michigan (158)
Minnesota (273)
New Jersey (967)
New York (961)
North Carolina (719)
Northern California (1485)
Ohio (139)
Pennsylvania (848)
South America (1157)
Southern California (1305)
Texas (470)
Washington State (367)
705,195 Results for "acumen pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
November 12, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference
November 7, 2024
·
1 min read
Business
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
Acumen Pharmaceuticals, Inc. reported financial results for the first quarter of 2024 and provided a business update.
May 14, 2024
·
12 min read
Press Releases
Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024
November 5, 2024
·
1 min read
BioCapital
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024, at 8:55 a.m. PT (11:55 a.m. ET).
May 8, 2024
·
1 min read
Press Releases
Acumen Health Holdings (“Acumen”) to Acquire the Avenova brand from NovaBay Pharmaceuticals
September 20, 2024
·
2 min read
Business
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced that the Company will report first quarter 2024 financial results on Tuesday, May 14, 2024.
May 7, 2024
·
1 min read
Press Releases
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
November 6, 2024
·
5 min read
BioCapital
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Conference on Monday, May 20, 2024, at 12:30 p.m. ET.
May 13, 2024
·
1 min read
BioCapital
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat as part of the Stifel 2024 CNS Days on Tuesday, March 19, 2024, at 12:00 p.m. ET.
March 12, 2024
·
1 min read
1 of 70,520
Next
